Publication | Closed Access

Incremental clinical and economic burden of suspected respiratory infections due to multi-drug-resistant Pseudomonas aeruginosa in the United States

Multi-drug-resistant Pseudomonas AeruginosaHealth SciencesAntibioticsHealthcare-associated InfectionRespiratory InfectionInfectious Respiratory DiseaseEconomic BurdenInfection ControlMedicineUnited StatesClinical MicrobiologyAntimicrobial ResistanceEpidemiologyDrug Resistance